Mutation and expression of the low affinity neurotrophin receptor in human malignant melanoma

Melanoma Research

Volumn 6, Issue 5, 1996, Pages 373-378

  Papandreou, C ^a   Bogenrieder, T ^a   Loganzo, F ^a   Chao, M V ^b   Nanus, D M ^a,b   Albino, A P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

melanocyte; melanoma; neurotrophin; p75 receptor

Indexed keywords

NEUROTROPHIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; CYTOLOGY; HUMAN; HUMAN CELL; MELANOMA; MUTATION; PRIORITY JOURNAL;

BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; HUMANS; MELANOCYTES; MELANOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED;

EID: 0029910296     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199610000-00004     Document Type: Article

References (37)

1. Elwood JB, Koh HK. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol 1994; 6: 179-187.
2. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994; 19: 219-240.
3. Albino AP, Fountain JW. The molecular genetics of malignant melanoma. In: Nathanson L, ed. Cancer Treatment and Research: Basic and Clinical Aspects of Malignant Melanoma. Boston: Martinus Nijhoff Publishers, 1993; 210-255.
4. Halaban R, Moellmann G. Proliferation and malignant transformation of melanocytes. Crit Rev Oncog 1991; 2: 247-258.
5. Mattei S, Colombo MP, et al. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994; 56: 853-857.
6. Rodeck U. Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metastasis Rev 1993; 12: 219-226.
7. Chao MV. The p75 neurotrophin receptor. J Neurobiol 1994; 25: 1373-1385.
8. Ross AH, Grob P, Bothwell M, et al. Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci USA 1984; 81: 6681-6685.
9. Herlyn M, Thurin J, Balaban G, et al. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985; 45: 5670-5676.
10. Herrmann JL, Menter DG, Hamada J-I, et al. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol Biol Cell 1993; 4: 1205-1216.
11. Barbacid M. Nerve growth factor: a tale of two receptors. Oncogene 1993; 8: 2033-2042.
12. Dobrowsky RT, Werner MH, Castellino AM, et al. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994; 265: 1596-1599.
13. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13: 151-153.
14. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969-976.
15. Houghton AN, Eisinger M, Albino AP, et al. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med 1982; 156: 1755-1766.
16. Albino AP, Davis BM, Nanus DM. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 1991; 51: 4815-4820.
17. Sudol M, Hanafusa H. Cellular proteins homologous to the viral yes gene product. Mol Cell Biol 1986; 6: 2839-2846.
18. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
19. Huber LJ, Chao MV. Mesenchymal and neuronal expression of the p75 neurotrophin receptor occur from different mechanisms. Dev Biol 1995; 167: 227-238.
20. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of beta-globin benomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.
21. Sehgal A, Patil N, Chao MV. A constitutive promoter directs expression of the nerve growth factor receptor gene. Mol Cell Biol 1988; 8: 3160-3167.
22. Orita M, Suzuki Y, Sekiya T, et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879.
23. Albino AP, Vidal M, McNutt NS, et al. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 1994; 4: 35-45.
24. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplication of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491.
25. Albino AP, Nanus DM, Mentle IR, et al. Analysis of ras oncogenes in malignang melanoma and precursor lesions: correlation of point mutations with diferentiation phenotype. Oncogene 1989; 4: 1363-1374.
26. Dicker AP, Volkenandt M, Albino AP. Mutational analysis of human NRAS genes in malignant melanoma: rapid methods for oligonucleotide hybridization and manual and automated direct sequencing of products generated by the polymerase chain reaction. Genes Chromosomes Cancer 1990; 1: 257-269.
27. Murray V. Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nuc Acids Res 1989; 17: 8889.
28. Rabizadeh S, Oh J, Zhong L-T, et al. Induction of apoptosis by the low-affinity NGF receptor. Science 1993; 261: 345-348.
29. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-1762.
30. Large TH, Weskamp G, Helder JC, et al. Structure and developmental expression of the nerve growth factor receptor in the chicken central nervous system. Neuron 1989; 2: 1123-1134.
31. Barker PA, Shooter EM. Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells. Neuron 1994; 13: 203-215.
32. Verdi JM, Birren SJ, Ibanez CF, et al. p75-lngfr regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron 1994; 12: 733-745.
33. Hempstead BL, Patil N, Thiel B, et al. Deletion of cytoplasmic sequences of the nerve growth factor receptor leads to a loss of high affinity ligand binding. J Biol Chem 1990; 265: 9595-9598.
34. Hantzopoulos PA, Suri C, Glass DJ, et al. The low affinity NGF receptor, p75, can collaborate with each of the trks to potentiate functional responses to the neurotrophins. Cell 1994; 13: 187-201.
35. Yan H, Chao MV. Disruption of cysteine-rich repeats of the p75 nerve growth factor receptor leads to loss of ligand binding. J Biol Chem 1991; 266: 12099-12104
36. Benedetti M, Levi A, Chao MV. Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci USA 1993; 90: 7859-7863.
37. Sherwin SA, Sliski AH, Todaro GJ. Human melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfaces. Proc Natl Acad Sci USA 1979; 76: 1288-1292.